![SafeCard Reviews [Urgent Update]: Read This Before Buying!](https://i2.wp.com/ml.globenewswire.com/Resource/Download/477cb65e-c680-499e-a698-922248eac853?w=150&resize=150,150&ssl=1 "SafeCard Reviews [Urgent Update]: Read This Before Buying!")
Bybit and Zodia Custody Partner to Enhance Asset Security
Zodia Custody's Interchange solution will offer Bybit's institutional clients independent custody and…
NYSE Content advisory: Pre-market update + ICE to explore digital asset use with Circle
NEW YORK, March 27, 2025 /PRNewswire/ -- The New York Stock Exchange…
Edelweiss Asset Management Recognized at the Morningstar Awards for Investing Excellence 2025
MUMBAI, India, March 24, 2025 /PRNewswire/ -- Edelweiss Asset Management Limited (EAML)…
Term Structure Institutional (TSI): The Future of Institutional Fixed-Rate Digital Asset Lending and Borrowing
HONG KONG, March 17, 2025 /PRNewswire/ -- Redefining Institutional Finance in the…
Robert Ventures Secures SEC Qualification for Innovative Real Estate and Digital Asset Investment Vehicle
Wilmington, DE , Feb. 21, 2025 (GLOBE NEWSWIRE) -- Today, Robert Ventures…
MANTRA Chain Launches Real-World Asset Accelerator Supported by Google Cloud
HONG KONG, Feb. 20, 2025 /PRNewswire/ -- MANTRA, a layer 1 blockchain purpose-built…
Radix Adds World-Class Supply Chain Resilience to Best-In-Class Asset Performance Management
HOUSTON, Jan. 26, 2025 (GLOBE NEWSWIRE) -- Radix, a global technology solutions…
Blockchain Security Meets Bitcoin Layer 2: True I/O and OroBit Join Forces to Transform Real-World Asset Markets
Carlsbad, CA , Jan. 21, 2025 (GLOBE NEWSWIRE) -- True I/O, a…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…